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Summary
Mitochondria are essential for neuronal survival and func-
tion. Proper degradation of aged and damagedmitochondria
through mitophagy is a key cellular pathway for mitochon-
drial quality control. Recent studies have indicated that
PINK1/Parkin-mediated pathways ensure mitochondrial
integrity and function [1–8]. Translocation of Parkin to
damaged mitochondria induces mitophagy in many non-
neuronal cell types [9–16]. However, evidence showing
Parkin translocation in primary neurons is controversial
[9, 15, 17, 18], leaving unanswered questions as to how
and where Parkin-mediated mitophagy occurs in neurons.
Here, we report the unique process of dissipating mitochon-
drial Dcm-induced and Parkin-mediated mitophagy in
mature cortical neurons. Compared with nonneuronal cells,
neuronal mitophagy is a much slower and compartmentally
restricted process, coupled with reduced anterograde
mitochondrial transport. Parkin-targeted mitochondria are
accumulated in the somatodendritic regions where mature
lysosomes are predominantly located. Time-lapse imaging
shows dynamic formation and elimination of Parkin- and
LC3-ring-like structures surrounding depolarized mitochon-
dria through the autophagy-lysosomal pathway in the soma.
Knocking down Parkin in neurons impairs the elimination
of dysfunctional mitochondria. Thus, our study provides
neuronal evidence for dynamic and spatial Parkin-mediated
mitophagy, which will help us understand whether altered
mitophagy contributes to pathogenesis of several major
neurodegenerative diseases characterized by mitochondrial
dysfunction and impaired transport.Results and Discussion
Mitochondrial Depolarization Induces Slower Parkin
Translocation in Mature Neurons
To examine whether mitochondrial depolarization induces
Parkin translocation in neurons, we performed three lines of
experiments. First, we treated mouse cortical neurons ex-
pressing YFP-Parkin and Discosoma species red fluorescent
protein (dsRed)-Mito at 9–10 days in vitro (DIV) for 24 hr with*Correspondence: cai@biology.rutgers.edu (Q.C.), shengz@ninds.nih.gov
(Z.-H.S.)vehicle dimethyl sulfoxide (DMSO) as a control, 10 mM
carbonyl cyanide m-chlorophenyl hydrazone (CCCP; a Dcm
dissipating reagent), or 10 mMCCCP with lysosomal inhibitors
(LIs; 10 mMpepstatin A and 10 mME64D). Although YFP-Parkin
was diffuse in the cytosol of DMSO-treated control neurons
(n = 435), it redistributed to mitochondria in 26.67% 6 4.46%
of neurons (n = 420) treated with CCCP and in 55.87% 6
6.57% of neurons treated with CCCP/LIs (n = 570) (Figures
1A and 1B). Treatment with CCCP/LIs doubled the percentage
of neurons with Parkin translocation relative to CCCP alone
(p < 0.001), suggesting that lysosomal degradation capacity
has a significant impact on the clearance of Parkin-targeted
mitochondria via mitophagy in neurons. Second, we coimmu-
nostained similarly treated neurons with antibodies against
neuronal marker MAP2 and mitochondrial markers TOM20
(an outer membrane protein) or cytochrome c (a dynamic inter-
membrane space protein). YFP-Parkin was recruited to mito-
chondria labeled with TOM20 or cytochrome c (Figure 1C) in
CCCP-treated neurons, but not in DMSO controls. To examine
Parkin translocation kinetics, we imaged neurons at various
time points during CCCP treatment. Parkin translocation
between 0.5–6 hr was exceptionally rare. Parkin-ring-like
structures surrounding fragmented mitochondria were occa-
sionally observed at as early as 12 hr and became increasingly
frequent after 18 hr of CCCP treatment (Figure 1D).
To determine whether endogenous Parkin undergoes
similar translocation after depolarization, we immunostained
cortical neurons at DIV10 with an anti-Parkin antibody
following 24 hr CCCP/LIs treatment. Whereas endogenous
Parkin appears as a diffuse pattern or as small puncta not
colocalized with mitochondria in DMSO-treated neurons,
treatment with CCCP/LIs induces endogenous Parkin recruit-
ment to mitochondria (Figure 1E). Alternatively, we isolated
the mitochondria-enriched membrane fraction from cultured
cortical neurons at DIV13 following the same treatment.
Although the majority of Parkin was in the cytosolic fraction,
treatment with CCCP/LIs induced endogenous Parkin to
associate with the mitochondria-enriched membrane (Fig-
ure 1F). Quantitative analysis showed a 2-fold (2.28 6 0.31)
increase in Parkin intensity in the mitochondrial fractions
following treatment with CCCP/LIs compared with DMSO
(p = 0.0014, n = 3). We also observed elevated levels of the au-
tophagicmarkers LC3-II and p62/SQSTM1 associatedwith the
mitochondria-enriched membrane fraction. Altogether, these
results indicate that mitochondrial depolarization can induce
the recruitment of both exogenous and endogenous Parkin
in mature neurons.
A gradual but slow increase in Parkin translocation during
prolonged CCCP treatment argues against the possibility
that CCCP becomes less effective over time in medium.
Spiked CCCP media, which had been incubated with neurons
for 24 hr, were still effective and sufficient to induce 23.95%6
2.49% of cultured neurons (fresh) to display Parkin transloca-
tion, a percentage close to that when using fresh CCCP
(26.67% 6 4.46%) at the same concentration (see Figure S1
available online). These results suggest that Parkin-mediated
mitophagy in neurons is a much slower process than in
other cell types reported. Treating HeLa cells with 10 mM
Figure 1. CCCP-Induced Recruitment of Parkin
to Mitochondria in Cortical Neurons
(A and B) Representative images (A) and quanti-
tative analysis (B) showing CCCP-induced Parkin
translocation to mitochondria. Cortical neurons
expressing YFP-Parkin and dsRed-Mito at DIV9
were treated for 24 hr with DMSO, 10 mM CCCP,
or 10 mM CCCP + LIs.
(C) CCCP-induced Parkin translocation to mito-
chondria labeled by mitochondrial marker
TOM20 (upper panels) or cytochrome c (lower
panels). Cortical neurons expressing YFP-Parkin
were treated with DMSO or 10 mMCCCP followed
by coimmunostaining with antibodies against
MAP2andTOM20orcytochromec. The right three
panels show enlarged views of the boxed area.
(D) Time course of Parkin translocation follow-
ing depolarization. Neurons at DIV8–10 were
imaged at sequential time points during CCCP
treatment.
(E) Endogenous Parkin translocation to mito-
chondria. Cortical neurons expressing dsRed-
Mito at DIV10 were treated with DMSO or CCCP/
LIs for 24 hr, followed by immunostaining with
a monoclonal Parkin antibody (Abcam). Note that
CCCP/LIs treatment induces the recruitment of
endogenous Parkin to mitochondria.
(F) Increased endogenous Parkin associates
with mitochondria following CCCP/LIs treatment
(red box) relative to that with DMSO control
(green box). Cortical neurons at DIV13 were
incubated with DMSO or 10 mM CCCP/LIs for
24 hr and then subjected to fractionation
into postnuclear supernatant (P), mitochondria-
enriched membrane pellet (M), and cytosol
supernatant (S). Protein lysates (10 mg) were
sequentially immunoblotted with antibodies
against Parkin (monoclonal, Santa Crutz) and
various markers including voltage-dependent
anion channel (mitochondria), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (cytosol), p62/SQSTM1 and LC3 (autophagy).
Scale bars represent 10 mm. Data was quantified from the number of neurons indicated in parentheses from three or four independent experiments.
Error bars represent SEM. Student’s t test.
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association with mitochondria in w80% of cells within 1–2 hr
[9–11, 17].
Parkin Is Selectively Recruited to Depolarized
Mitochondria
To examine whether Parkin-targeted mitochondria display
dissipated Dcm, we pulsed live neurons expressing YFP-
Parkin and CFP-Mito with tetramethylrhodamine ethyl ester
(TMRE), a Dcm-dependent dye. Active or healthy mitochondria
will accumulate TMRE to have higher TMRE intensity. In
DMSO-treated neurons or neurons recovered from CCCP
treatment (no Parkin translocation), the majority of CFP-
Mito-labeled mitochondria were colabeled by TMRE, reflect-
ing their electrochemically active status (Figure 2A). In
contrast, somatic mitochondria with YFP-Parkin translocation
displayed reduced or no TMRE staining, suggesting that
YFP-Parkin is selectively recruited to depolarized mitochon-
dria (Figures 2A and 2B). We quantified the TMRE mean inten-
sity in somas and normalized to that in DMSO control neurons
(Figure 2C). Neurons with Parkin translocation exhibited a
48.3% 6 4.7% (n = 17; p < 0.001) reduction in the TMRE
mean intensity relative to recovered neurons (95.9% 6 5.3%
n = 16) and DMSO-treated controls (n = 16). Time-lapse
TMRE imaging in live cortical neurons demonstrates that acute
incubation with 10 mM CCCP during an 11 min recording issufficient to globally depolarize Dcm (Figure S2B). Further-
more, Parkin was gradually recruited to mitochondria in the
soma during a 52 min recording time (Figure 2D; Movie S1).
To determine whether endogenous Parkin is critical for
eliminating mitochondria with dissipated Dcm, we suppressed
Parkin expression using an RNA interference (RNAi) approach.
Cortical neurons were transfected with Parkin small interfering
RNA (siRNA) or control siRNA at DIV0 and endogenous
Parkin levels were then assessed by immunoblot. Parkin-
siRNA specifically and efficiently reduced endogenous Parkin
expression to 26.10% 6 7.96% (n = 3) of control levels (Fig-
ure 2E). Knocking down Parkin impaired the elimination of
dysfunctional mitochondria, leading to accumulation of mito-
chondria with reduced TMRE intensity (Figures 2F and 2G).
After 24 hr CCCP treatment, 66.91% 6 2.00% of control
neurons (n = 130) recovered mitochondrial TMRE intensity,
versus 19.27% 6 2.01% (n = 97, p < 0.001) of Parkin loss-of-
function neurons (Figure 2G). These results support our
hypothesis that Parkin-mediated mitophagy is one of the
unique neuronal mechanisms to maintain mitochondrial integ-
rity and function in response to dissipating Dcm. Our RNAi
data are consistent with a previous report demonstrating
mitochondrial dysfunction and oxidative damage in Parkin-
deficient mice [2].
Previous reports noted an absence of Parkin translocation
after acute CCCP treatment of primary cortical neurons [15]
Figure 2. Selective Parkin Recruitment to Depolarized Mitochondria
(A–C) Representative images (A and B) and quantitative analysis (C) showing translocation of YFP-Parkin to depolarized mitochondria. Cortical neurons
expressing YFP-Parkin and CFP-Mito at DIV9 were treated with DMSO or 10 mM CCCP for 24 hr followed by loading with mitochondrial Dcm-dependent
dye TMRE for 30min prior to imaging. Arrows indicate depolarizedmitochondria labeled by CFP-Mito but unlabeled by TMRE. Arrowheads represent polar-
ized mitochondria marked by both CFP-Mito and TMRE, which are unlabeled by Parkin. TMRE mean intensity was normalized to DMSO control neurons.
Note that neurons recovered from CCCP-treatment maintain normal TMREmean intensity (p < 0.60), whereas neurons displaying Parkin translocation have
reduced TMRE mean intensity in the soma (p < 0.001) relative to that of control neurons.
(D) Time-lapse imaging of live cortical neurons showing slow and dynamic recruitment of YFP-Parkin to mitochondria in the soma. Neurons were treated for
24 hr with 10 mMCCCP, followed by 52min time-lapse imaging. Graphs to the right are line scans of relative dsRed-Mito and YFP-Parkin fluorescence inten-
sities in the images at respective time points (left panels).
(E) siRNA-mediated Parkin knockdown in neurons. Cortical neurons were transfected with Parkin-siRNA or control siRNA at DIV0 and protein was harvested
at DIV4. Protein lysates (10 mg) were sequentially immunoblotted with antibodies against Parkin and various markers including HSP60 and Tom20
(mitochondria), p115 (Golgi), GAPDH (cytosol).
(FandG)Representative images (F) andquantitativeanalysis (G)showingaccumulationofdepolarizedmitochondriabyknockingdownParkin incortical neurons,
leading to more mitochondria with reduced or no TMRE staining following CCCP treatment. Arrows point to mitochondria with high TMRE intensity (con small
hairpinRNA[shRNA])or lowTMREintensity (Parkin-shRNA).CFP-Mito*:color isconverted fromcyantogreenforbettercontrast.Quantitativedatawasexpressed
as normalized TMREmean intensity in the soma (upper graph) or percentage of neuronswith recovered TMRE intensity followingCCCP treatment (lower graph).
Data were collected from the number of neurons indicated in parentheses from three independent experiments. Scale bars in (A) and (F) represent 10 mmand
in (B) and (D) represent 5 mm. Error bars represent SEM. Student’s t test.
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548and in dopaminergic neurons with the loss of mitochondrial
DNA (mtDNA) [18]. The latter study suggests two different
neuronal responses to damaged mitochondria: one for acute
Dcm dissipation by depolarizing reagents and one for slow
progressive deterioration ofmitochondrial function by deleting
mtDNA in vivo. Thus, Parkin-mediated mitophagy likely serves
to ensure neuronal mitochondrial integrity by eliminating
severely damaged mitochondria with lost Dcm [18]. Our study
reveals that neuronal mitophagy is a slower process. In
response to 24 hr CCCP treatment, only a small percentage
of neurons displayed detectable Parkin translocation, whereas
mitochondria in the majority of neurons recover Dcm. In
addition, the efficacy of Parkin-mediated mitophagic flux in
neurons is controlled by lysosomal degradation capacity. It
is unclear how neurons recover their Dcm following prolonged
CCCP treatment in culture. Unlike most cells, neurons are
wholly dependent uponmitochondrial respiration, thus special
mechanisms are required to recover damaged mitochondria
after global depolarization. We propose that lysosomal func-
tion, proper Parkin expression, slow Parkin translocation,
and the elimination of dysfunctional mitochondria are impor-
tant factors for Dcm recovery. In addition, the quality of the
neuronal culture is critical to create optimal survival conditions
following CCCP treatment; if not met, the uncoupled mito-
chondria may quickly initiate an apoptotic process before
Parkin translocation can be observed. We have established
a high neuronal culture quality to meet our live neuron imaging
standards with minimal enzymatic, mechanical, chemical, and
oxidative damage [19, 20] (see Supplemental Experimental
Procedures).
Parkin-Targeted Mitochondria Accumulate in the
Somatodendritic Regions
We examined the distribution of Parkin-targeted mitochondria
in neurons treated with CCCP/LIs. Translocated YFP-Parkin
forms typical ring-like structures surrounding fragmented
mitochondria, which predominantly accumulate in the soma
and proximal dendritic regions but are hardly detectable in
axons and the distal dendritic processes (Figure 3A), suggest-
ing that depolarized mitochondria are selectively accumulated
in the somatodendritic regions after prolonged CCCP treat-
ment. Such unique compartmental restrictionwas consistently
observed in neurons treated with a second Dcm dissipating
reagent antimycin A (1 mM) or the selective ATP synthase inhib-
itor oligomycin (1 mM) (Figures S2C, S2D, and S3).
This unique distribution pattern suggests that depolarized
mitochondria undergo altered transport following prolonged
CCCP treatment. To test this possibility, we examined relative
mitochondrial mobility following 24 hr CCCP treatment. We
selected axons for measuring mitochondrial mobility due to
their uniform microtubule organization and polarity. Axonal
processes were selected as we previously reported [19, 20]
(Supplemental Experimental Procedures). Kymographs were
used to quantify relative mobility. In DMSO-treated neurons,
42.7% 6 2.3% (mean 6 SEM) of axonal mitochondria are
stationary and 57% of mitochondria are mobile, where
35.9% 6 2% undergo anterograde transport and 21.3% 6
2% undergo retrograde transport. In contrast, in neurons
with Parkin translocation, anterograde transport was reduced
to 13.3% 6 2% (p < 0.001), whereas retrograde transport was
relatively increased (36.12% 6 3.67%, p = 0.002), accompa-
nied by reduced velocity and altered flux of axonal mitochon-
dria (Figures 3B–3D). In recovered neurons without Parkin
translocation after CCCP treatment, mobility parameterswere similar or slightly changed compared to those in
DMSO-treated neurons.
Altered mitochondrial mobility may be protective for neu-
rons under stressful conditions, where healthy mitochondria
remain distally, whereas damaged mitochondria return to the
soma for degradation. To test this hypothesis, we overex-
pressed syntaphilin (SNPH), a neuronal mitochondria docking
protein that anchors mitochondria to microtubules, to artifi-
cially immobilize mitochondria in distal processes [19]. To
our surprise, the distribution of Parkin-targeted mitochondria
in neurons changed strikingly following CCCP treatment;
Parkin was recruited to arrested mitochondria in distal neu-
ronal processes (Figure 3E). This artificial phenotype suggests
that once distal mitochondria are immobilized, they will even-
tually recruit Parkin. Thus, somatodendritic accumulation of
Parkin-targeted mitochondria may be coordinately attributed
to several factors including (1) reduced anterograde and
relatively enhanced retrograde transport leading to more de-
polarized mitochondria accumulated in the somatodendritic
regions during prolonged CCCP treatment and (2) immobiliza-
tion of mitochondria after slow Parkin translocation, resulting
in reduced anterograde flux of damaged mitochondria
into distal processes (Figures 3C and 3D). Therefore, a
Parkin-mediated process prevents dysfunctional mitochon-
dria from traveling peripherally. Consistently, we observed
that Parkin-targeted mitochondria in the soma remain
stationary throughout time-lapse recording. This hypothesis
is consistent with previous studies showing reduced levels
ofmotor and adaptor proteins uponCCCP-inducedmitophagy
[12, 13] and a recent report showing that Parkin-dependent
degradation of Miro arrests mitochondrial movement [21].
The correlation between Dcm and mitochondrial mobility is
controversial, especially following acute treatment of neurons
with high concentrations of Dcm dissipating reagents [22, 23].
In one study with JC-1 staining and acute depolarization with
much higher concentrations of antimycin A (100 mM), 90% of
mitochondria with high Dcm moved in the anterograde direc-
tion, whereas 80% with low Dcm moved in the retrograde
direction [22]. Interestingly, acutely applying a much higher
concentration of CCCP (1mM) blocks mitochondrial transport.
Another study with TMRM staining showed no correlation
between Dcm and the direction of axonal mitochondrial
transport in sensory neurons [23]. In our study, we instead
examined mitochondrial mobility after neuron recovery from
24 hr treatment with a lower concentration of CCCP (10 mM),
allowing us to assess the correlation between mobility and
slow Parkin translocation. Prolonged Dcm dissipation may
allow the proceeding slow events to induce mobility changes
in neurons, which is supported by our observations that
only neurons with Parkin translocation displayed reduced
anterograde movement.
Parkin-Targeted Mitochondria Are Eliminated through
the Autophagy-Lysosomal Pathway in Somas
To determine whether Parkin-targeted mitochondria are
degraded via the autophagy-lysosomal pathway, we labeled
autophagic vacuoles with GFP-LC3 [20]. In DMSO-treated
conditions, GFP-LC3 was cytosolic (Figure 4A). However,
CCCP treatment resulted in LC3-labeled ring-like structures
surrounding fragmented mitochondria in the somatodendritic
regions. Treating neurons with both CCCP and LIs produced
more LC3-labeled mitochondria (yellow) and other autophagic
vacuoles (green). These imaging results are consistentwith our
biochemical observations showing elevated LC3-II and p62
Figure 3. Altered Mitochondrial Transport during Slow Parkin Translocation
(A) Representative images showing CCCP-induced Parkin translocation to mitochondria accumulated in the somatodendritic regions. Cortical neurons at
DIV9 were treated for 24 hr with 10 mM CCCP/LIs.
(A-a) Enlarged views of the boxed somatodendritic area. Arrows indicate Parkin ring-like structures surrounding fragmented mitochondria, whereas an
arrowhead marks mitochondria unlabeled by Parkin.
(A-b) Enlarged views of a dendritic process showing no Parkin-labeled mitochondria at distal regions.
(B–D) Representative kymographs (B) and quantitative analysis (C andD) showing that Parkin translocation is accompanied by alteredmobility, velocity, and
flux of axonal mitochondria. Cortical neurons at DIV9 were treated with DMSO or 10 mM CCCP for 24 hr, followed by 15 min time-lapse recordings. Vertical
lines represent stationary organelles, oblique lines, or curves to the right represent anterograde transport, and lines to the left indicate retrogrademovement.
Relative mitochondrial mobility was quantified from the number of neurons (C) or the number of mitochondria and axons (D) indicated in parentheses.
Note that neurons recovered from CCCP display normal or slightly altered transport, whereas neurons with Parkin translocation show significant changes
in mitochondrial mobility.
(E) Immobilizing mitochondria by expressing SNPH results in Parkin recruitment to distal mitochondria. Cortical neurons coexpressing SNPH (upper panel)
or without SNPH overexpression (lower panel) were treated with CCCP/LIs for 24 hr at DIV9. Arrows point to Parkin-targeted distal mitochondria and arrow-
heads indicate Parkin-negative distal mitochondria in a control neuron.
Error bars represent SEM. Student’s t test. Scale bars represent 10 mm.
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ization (Figure 1F). To determine whether depolarized mito-
chondria were retained within lysosomal organelles upon
lysosomal inhibition, we expressed GFP-LAMP1, a lysosomalmembrane protein. In DMSO-treated neurons, there was little
colocalization (2.72% 6 0.31%) between mitochondria and
lysosomes (Figure 4B). In contrast, treatment with CCCP/LIs
significantly enhanced the recruitment of mitochondria to
Figure 4. Parkin-Targeted Mitochondria Are Degraded through the Autophagy-Lysosomal Pathway in the Somatodendritic Regions
(A) Representative images showing CCCP-induced LC3 recruitment to depolarized mitochondria. Cortical neurons expressing GFP-LC3 and dsRed-Mito
at DIV9 were treated with DMSO, 10 mM CCCP, or 10 mM CCCP/LIs for 24 hr. Arrows indicate colocalization of mitochondria with GFP-LC3.
(B) CCCP-induced colocalization of mitochondria and lysosomes (indicated by arrows). Neurons expressing GFP-LAMP1 and dsRed-Mito at DIV9 were
treated with DMSO or 10 mM CCCP/LIs for 24 hr.
(C) Time-lapse imaging showing dynamic emergence and disappearance of Parkin and LC3-labeled autophagic vacuoles in the somatodendritic regions.
Neurons expressing GFP-LC3 and mCherry-Parkin were treated for 24 hr with 10 mMCCCP, followed by time-lapse imaging. Whereas colocalized ring-like
structures of mCherry-Parkin andGFP-LC3 (white arrows) gradually disappeared, some new puncta (red arrows) emerged during the 25min recording time.
(D) Time-lapse imaging showing disappearance of a Parkin-associated mitochondrion (#1) in the soma following treatment with 10 mM CCCP. Lower panel
shows normalized dsRed-Mito fluorescence intensity of the mitochondrion #1 (Parkin-positive) and #2 (Parkin-negative). Fluorescence intensity for Mito #1
gradually disappears during a 38 min recording period. DsRed-Mito fluorescence intensity of Mito #2 remained consistent throughout the imaging
acquisition. Fluorescence intensity of each mitochondrion was normalized to their intensity at t = 18 min. Scale bars in (A) and (B) represent 10 mm and
in (C) and (D) represent 5 mm.
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551LAMP1-labeled lysosomes in the soma (32.10% 6 2.17%,
p < 0.001). This indicates that proper lysosomal function is
required to efficiently eliminate damaged mitochondria.
We next examined Parkin and LC3-labled mitochondrial
dynamics in the somatodendritic regions (Figure 4C). During
a 25 min time-lapse recording of the soma, ring-like vesicular
structures colabeled with GFP-LC3 and mCherry-Parkin
disappeared, whereas new puncta emerged. Furthermore,
a ring-like Parkin-associated mitochondrion, as opposed to
the Parkin-negative mitochondria in the same image, disap-
peared over a 38 min time-lapse recording period (Figure 4D;
Movie S2). Both the Parkin-ring structure and the mitochon-
drion were eliminated, whereas the Parkin-unlabeled mito-
chondrion remained. Thus, our study provides live neuronal
evidence showing degradation of Parkin-targeted mitochon-
dria through the autophagy-lysosomal pathway.
Although somatodendritic Parkin-mediated mitophagy is
readily and consistently detected in our cultures, it was hardly
detectable along distal axonal processes. Alternatively, GFP-
LC3 in cortical neurons was recruited to axonal mitochondria
following 24 hr treatment with CCCP/LIs (Figure S4). Thus,
axonal mitochondria may undergo either Parkin-mediated mi-
tophagy at undetectable Parkin signals or Parkin-independent
mitophagy. Further investigation is required to determine the
main mechanism for axonal mitochondrial quality control.
Dysfunctional mitochondria not only produce energy less
efficiently, but also release harmful reactive oxygen species
and initiate apoptotic signaling cascades, all linked to the
pathogenesis of major neurodegenerative disorders [24–28].
Sequestration and elimination of aged and damaged mito-
chondria is an important but poorly characterized neuronal
mechanism. In the current study, we reveal several unique
features of Parkin-mediated mitophagy in mature cortical
neurons. First, Parkin translocation onto mitochondria is
slower than in nonneuronal cells. Second, Parkin is selectively
recruited to depolarized mitochondria to form ring-like
structures. Third, following 24 hr CCCP incubation, Parkin
translocation only occurs in a small percentage of neurons.
Lysosomal degradation is critical for the efficacy of Parkin-
mediated mitophagy. Fourth, Parkin translocation is restricted
to the somatodendritic regions, where mature and acidic
lysosomes are predominantly localized [20, 29, 30]. This
spatial and dynamic process allows neurons to efficiently
eliminate dysfunctional mitochondria. Therefore, our study,
for the first time, shows selective and dynamic Parkin translo-
cation to depolarized mitochondria and subsequent degrada-
tion via the autophagy-lysosomal pathway in live neurons.
Experimental Procedures
Animal care and use were carried out in accordance with National Institutes
of Health (NIH) guidelines and approved by the NIH and National Institute of
Neurological Disorders and Stroke (NINDS)/National Institute on Deafness
and Other Communication Disorders (NIDCD) Animal Care and Use
Committee.
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